CAS 163768-50-1

Auristatin F

CAS: 163768-50-1

Auristatin F

Formula: C₄₀H₆₇N₅O₈

Purezza: 99%

Peso molecolare: 745.99

Ref: 54-OR1024019

N,N-Dimethyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-L-phenylalanine

CAS: 163768-50-1

Formula: C₄₀H₆₇N₅O₈

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 745.9887

Ref: IN-DA00ABIO

Auristatin F

CAS: 163768-50-1

Auristatin F

Formula: C₄₀H₆₇N₅O₈

Purezza: ≥98%

Peso molecolare: 745.99

Ref: 54-BUP11580

Auristatin F-d8

CAS: 163768-50-1

Formula: C₄₀H₅₉D₈N₅O₈

Peso molecolare: 754.05

Ref: 4Z-PA-329005

Auristatin F

CAS: 163768-50-1

Formula: C₄₀H₆₇N₅O₈

Peso molecolare: 746.00

Ref: 4Z-PA-329004

Auristatin F

CAS: 163768-50-1

(S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(Dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid

Formula: C₄₀H₆₇N₅O₈

Purezza: 99%

Peso molecolare: 745.99

Ref: IN-DG630408

Auristatin F

CAS: 163768-50-1

Ref: BE-RMCP470004

Auristatin F TFA Salt

Prodotto controllato

CAS: 163768-50-1

Stability Hygroscopic
Applications Auristatin F is an antimitotic auristatin derivative that has been shown as a potent antitumor agent.
References Doronina S.O., et al.: Bioconjugate Chem., 17, 114-124 (2006);

Formula: C₄₀H₆₇N₅O₈•x(C₂HF₃O₂)

Colore e forma: Neat

Peso molecolare: 745.9911402

Ref: TR-A794100

Auristatin F

CAS: 163768-50-1

Auristatin F is an effective inhibitor of microtubule and vascular damaging agent. Auristatin F can be used in antibody-drug conjugates.

Formula: C₄₀H₆₇N₅O₈

Purezza: 98.41% - 99.25%

Colore e forma: White Solid

Peso molecolare: 745.99

Ref: TM-T14349

Auristatin F TFA Salt

CAS: 163768-50-1

Auristatin F TFA salt is a potent antitumor agent that can be used for the treatment of solid tumours. It inhibits the growth of cancer cells by binding to epidermal growth factor (EGF) receptors and blocking the action of EGF. Auristatin F TFA salt has been shown to induce apoptosis in prostate cancer cells and can also act as a potential biomarker for tumour response. The drug is not toxic to healthy cells, but it is rapidly eliminated from the body due to its short half-life. Auristatin F TFA salt has been shown to have pharmacokinetic properties that are similar in mice, rats, and humans. This drug also binds monoclonal antibodies against EGFR, which may serve as an alternative treatment for cancer patients who develop resistance to temozolomide.

Formula: C₄₀H₆₇N₅O₈•(C₂HF₃O₂)x

Purezza: Min. 95%

Peso molecolare: 745.99 g/mol

Ref: 3D-NGA76850